CD8A and lung carcinoma: Garcia et al. [7] found that tumour effector CD8+ T cells were susceptible to negative regulation by PD-L1 when not fully differentiated into effector cells, and that the PD-L1/PD-1 pathway could inhibit the function of tumour effector T cells in the MPE of lung cancer patients.